Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.
about
Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body.Effects of meal and incretins in the regulation of splanchnic blood flow.18F-FDG uptake in the colon is modulated by metformin but not associated with core body temperature and energy expenditure.Two weeks of moderate-intensity continuous training, but not high-intensity interval training, increases insulin-stimulated intestinal glucose uptakeOrgan-specific physiological responses to acute physical exercise and long-term training in humans.Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgeryThe role of beneficial bacteria wall elasticity in regulating innate immune response.A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.A Partial Loss-of-Function Variant in AKT2 Is Associated With Reduced Insulin-Mediated Glucose Uptake in Multiple Insulin-Sensitive Tissues: A Genotype-Based Callback Positron Emission Tomography Study.Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.Type 2 diabetes mellitus
P2860
Q30991322-A84C7283-9387-4912-8933-EFC6645EA84CQ31170579-B6AAF708-6DAC-47AC-86C5-438BBA1F98D3Q33626631-45E07AC1-EF41-41AF-BEEC-EE15BD70297FQ33747462-0ED7B7E0-18CC-42BC-A4BB-4D8F06B3DB1DQ34445824-45462698-5FCF-4909-8E3C-507FC54A87B0Q35350002-E22B608F-8D26-4EA6-8178-122A1312F98DQ35776698-1B0E045C-4FE0-4E7D-92C4-00519AA80D5DQ42707414-0F592B5E-B4AE-4E18-9DD4-EAA0164DB527Q47590663-5D5CB7EF-29A9-4130-91B2-B63B8EDFD8A4Q48202708-6DFF14C5-C070-4747-938C-4F9491938447Q58447602-D5EC3358-076E-4EBB-AC35-AA709CDA3E86
P2860
Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Validation of [18F]fluorodeoxy ...... patients with morbid obesity.
@en
Validation of [18F]fluorodeoxy ...... patients with morbid obesity.
@nl
type
label
Validation of [18F]fluorodeoxy ...... patients with morbid obesity.
@en
Validation of [18F]fluorodeoxy ...... patients with morbid obesity.
@nl
prefLabel
Validation of [18F]fluorodeoxy ...... patients with morbid obesity.
@en
Validation of [18F]fluorodeoxy ...... patients with morbid obesity.
@nl
P2093
P2860
P50
P1433
P1476
Validation of [18F]fluorodeoxy ...... n patients with morbid obesity
@en
P2093
P Salminen
P2860
P2888
P304
P356
10.1007/S00125-012-2825-5
P577
2013-01-20T00:00:00Z